Tuesday, November 17, 2020

Roche Diabetes Care joins hands with Maharashtra Health Department to provide true relief to underprivileged diabetics

 

  • On World Diabetes Day 2020, Roche spreads awareness and education about diabetes
  • Extends outreach to 4000 underprivileged diabetics Maharashtra, 17 November 2020: Roche Diabetes Care and the Maharashtra Health Department have partnered in their commitment to create a comprehensive ecosystem of care for diabetes management, and to strengthen the ongoing efforts by the Health Department to manage diabetes in Maharashtra. Supporting the government’s efforts to provide free insulin to children with diabetes, Roche Diabetes Care has extended DiaBeaters, a diabetes awareness programme, with the distribution of 4000 Accu-Chek Instant S glucometers free of cost to underprivileged diabetics in Jalna, Maharashtra on World Diabetes Day 2020. This is to ensure that those afflicted and unable to afford glucometers for self- monitoring of blood glucose, can now keep their diabetes in check.

 

Speaking about this, Omar Sherief Mohammad, Country Head, Roche Diabetes Care India, said, “We are proud to partner with the Maharashtra Government in our commitment to create a comprehensive care ecosystem for the underprivileged through diabetes awareness-building, education and screening. Through the DiaBeaters initiative, this donation of glucometers reinforces the important message of daily monitoring and the critical role of self-monitoring of blood glucose and providing true relief to those who are in need.”

 

Emphasizing the various efforts by Maharashtra Health Department for improving diabetes care in the state, Shri Rajesh Tope, Maharashtra Health Minister, said, “The Maharashtra Government has been working tirelessly in the state to improve diabetes screening, diabetes management and lower the risk of complications. Glucose monitoring and regular medication are a vital part of diabetes management. We are pleased to have Roche Diabetes Care partner with us for an initiative to improve diabetes management of our brothers and sisters who suffer from diabetes and are unable to afford glucometers for self- monitoring of blood glucose.”

 

The DiaBeaters awareness programme was launched earlier this year with the aim to build awareness among children, parents and teachers about diabetes. Through engaging and informative multimedia materials delivered in a virtual classroom, the DiaBeaters programme provides information on diabetes prevention and management. The pilot programme reached 4,300 children in nine schools across Delhi, Chennai and Bangalore; in its next phase the DiaBeaters programme will be expanded through strategic alliances with like-minded partners in the public and private sectors.

 

Roche Diabetes Care is working towards Integrated Personalised Diabetes Management (IPDM) solutions in India and in line with the Government’s vision of providing affordable healthcare to all citizens; Roche is working with healthcare providers to create patient-centered products and solutions for convenient, affordable and effective diabetes management.  

 

About Roche Diabetes Care

Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.

 

Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualise relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments. For better outcomes and true relief.

 

Since 2017, mySugr one of the most popular diabetes management apps is part of Roche Diabetes Care.

 

For more information, please visit www.rochediabetes.comwww.accu-chek.com and www.mysugr.com.

 

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

 

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

 

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

 

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.


All trademarks used or mentioned in this release are protected by law.

For more information please contact: 

Koeyli Jaluka 

Head – Public Affairs, Communications & CSR
Roche Diabetes Care India                                                              

No comments: